Mark Mossler, Chief Accounting Officer: C4 Therapeutics CCCC Planned sale · Filed 08/14

Trade details

Type: Planned sale notice
Stock: C4 Therapeutics CCCC
Person: Mark MosslerChief Accounting Officer
Planned sale date: 26/08/14
Filed: 26/08/14

More to sell after $173.2K in 3 months

C4 Therapeutics trades, last 26 weeks

What else happened in C4 Therapeutics around then

Filed or reported within 30 days of the trade day · 07/15~09/13

Mark Mossler's recent trades

Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$61.1K
15,000 sh
$61.1K
Filed 08/13
Traded 08/13
Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$76.7K
19,519 sh
$76.7K
Filed 08/12
Traded 08/12
Mark MosslerChief Accounting Officer
Planned saleC4 Therapeutics
Planned sale
C4 Therapeutics
CCCC
$35.5K
9,087 sh
$35.5K
Filed 05/28
Traded 05/27